澳大利亚的肝细胞癌监测:当前和未来的前景
Samuel Hui1,2, Sally Bell1,2, Suong Le1,2
1School of Clinical Sciences at Monash Health, Monash University, Melbourne, VIC.
The Medical journal of Australia
|October 7, 2023
概括
肝细胞癌 (HCC) 查减少了癌症死亡,但由于患者,临床医生和系统障碍,其吸收率较低. 需要新的策略和工具来改善HCC监测和护理.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 在瘤学瘤学.
- 公共卫生 公共卫生
背景情况:
- 肝细胞癌 (HCC) 是全球癌症死亡的主要原因,澳大利亚的发病率正在上升.
- 目前针对肝硬化和慢性乙型肝炎的HCC查建议包括每6个月一次超声波检查,但许多诊断发生在疾病晚期的监测之外.
研究的目的:
- 审查HCC监测的有效性,危害和障碍.
- 探讨在HCC病例发现和监测策略方面的潜在改进.
主要方法:
- 文献综述和对有关HCC监测有效性,吸收率和成本效益的现有数据的分析.
- 讨论针对个性化HCC监测的新兴技术和策略.
主要成果:
- 据信,HCC监测可以降低死亡率,但潜在的危害尚未完全理解.
- 监测采用率低于最佳程度的原因是患者,临床医生和系统层面的障碍.
- 新的预测模型和成像技术可能会增强未来个性化的HCC监测.
结论:
- 改善病例发现策略是必要的,特别是在患有肝硬化或病毒性肝炎的无症状个体中.
- 需要进一步的澳大利亚数据来确认成本效益.
- 一个集中的HCC监测计划可以改善护理公平性和结果.
更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.9K
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
490
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:26Diseases of the Liver and Gallbladder
597
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
597